|
Past Audio Conferences
|
|
New Fee Arrangement for Patent Litigation
|
|
|
|
|
Avoiding Disclosure and Financial Reporting Traps in an Uncertain Economy
|
|
|
|
|
Interim Executives Allow Hospitals to Find The Right Fit — Examining the Case of Interim Compliance Officers
|
|
|
|
|
The Strategic Use of Computer Forensics—Assuring Cost-Effective Defensibility in Economically Challenging Times
|
|
|
|
|
The “New” Miller Bill: How Will the 401(k) Fair Disclosure and Pension Security Act of 2009 Affect Plan Fiduciaries and their Providers?
|
|
|
|
|
Unclaimed Property Law: Everything You Need To Know Before November 1
|
|
|
|
|
The SEC Enters the Fray Around “Pay to Play”
|
|
|
|
|
Global Data Security Issues: Where the Law Is and Where It’s Going
|
|
|
|
|
Strategic Use of Inter Partes Reexamination and Tactical Interplay with Patent Litigation
|
|
|
|
|
Hot Topics in Medical Research: Noncompliance, Medicare Billing, and Conflicts of Interest
|
|
|
|
|
Electronic Discovery and Evidence in Criminal Actions
|
|
|
|
|
SEC Enforcement Initiatives: What the Changes Mean for Counsel and their Clients
|
|
|
|
|
Hedge Fund Enforcement and Regulatory Update
|
|
|
|
|
ERISA Class Actions – Up Close and Personal: An In Depth Look At The Myriad Of Complex And Ever-Evolving Issues
|
|
|
|
|
New Markman and Reexamination Strategies in Light of Changes to the Marketplace and Legal Landscape
|
|
|
|
|
The Realities and Myths of Patenting in India
|
|
|
|
|
Navigating the American Recovery and Reinvestment Act (ARRA) Minefield for Contractors
|
|
|
|
|
Is Your Compensation Committee Ready for the Executive Compensation Disclosure and Governance Changes?
|
|
|
|
|
Lobbying and Political Law 2009: Complying with State Pay to Play, Ethics, and Lobbying Laws
|
|
|
|
|
2009 False Claims Act Amendments: Implications for the Health Care Community (Part II- Liability Provisions)
|
|
|
|
|
Lobbying and Political Law 2009: Internal Compliance Audits for General Counsel
|
|
|
|
|
Putting Litigation Back Into E-Discovery
|
|
|
|
|
2009 False Claims Act Amendments: Implications for the Health Care Community (Part I- Procedural Provisions)
|
|
|
|
|
Assessing the Impact of the Delaware Corporate Law Amendments and the SEC's Shareholder Proxy Access Proposal
|
|
|
|
|
E-Discovery in Patent Cases
|
|
|
|
|
Hot Topics in Class Actions: A Perspective from Plaintiffs, Defendants, and the Academic Community
|
|
|
|
|
Meat and Potatoes or Cotton Candy? A Survey of Patent Analytics Tools and Services
|
|
|
|
|
Working with Rule 502: Perils and Promises
|
|
|
|
|
Will There be Any Software Patents to Litigate after Bilski, Comiskey, and Muniauction?
|
|
|
|
|
Practical Steps To Prepare For The HITECH Act: What Health Care Providers Should Know
|
|
|
|
|
Effective Strategies for Handling the Shift in Negotiating Power Away From the Patent Holder
|
|
|
|
|
Antitrust Developments in Complex Litigation: Where are we after Twombly, Hydrogen Peroxide, and CAFA?
|
|
|
|
|
Understanding the Basics and Navigating through the Challenges of State Unclaimed Property Laws
|
|
|
|
|
Planning for a Post-Levine World: Implications and Strategies for Manufacturers, U.S. Consumers and the Courts
|
|
|
|
|
Reincorporation in North Dakota: Why Shareholders Want to Go West
|
|
|
|
|
Maximizing Success in Patent Prosecution
|
|
|
|
|
The Red Flags Rule: FTC Officials Will Discuss Legal Requirements and Compliance
|
|
|
|
|
The Patent Disclosure, Serves Different Roles for Different People with Different Viewpoints: Drafting the Specification to Cover All the Angles
|
|
|
|
|
Privacy in a Time of Great Change: The Revolution in Health Care Privacy Law and the New Overall Obama Agenda For Privacy
|
|
|
|
|
Dissecting the COBRA Subsidy Requirements
|
|
|
|
|
Sponsor-CRO Relationships: Managing Risk
|
|
|
|
|
Patent Eligible Subject Matter under 35 USC 101: Working with the Machine or Transformation Test in Litigation and Prosecution
|
|
|
|
|
Can the Public-Private Partnership and TALF Jump-Start the Market for Commercial Mortgage-Backed Securities?
|
|
|
|
|
|
|
|
|
Economic Stimulus Package: HIPAA Amendments and Health IT Funding
|
|
|
|
|
Is the “Chihuahua” ready to put some bite in its bark? Have the practices of Board Compensation Committees responded to the 2004 criticisms of Mr. Buffett?
|
|
|
|
|
The Key Differences Between US and European Patent Law
|
|
|
|
|
Riding the Tidal Wave of 401(k) Fiduciary Lawsuits
|
|
|
|
|
ERISA Plan Administration and Divorce Waivers After Kennedy v. Plan Admin. for DuPont Savings and Invest. Plan
|
|
|
|
|
Medical Tourism: From Idea to Implementation
|
|
|
|
|
Clinical Trials Billing Auditing and Monitoring Strategies for 2009 and Beyond
|
|
|
|
|
Executive Compensation Disclosure Update – 2009 Proxy Season, Part 2
|
|
|
|
|
Your Adversary is Prepared, Are You? Strategies for Preparing to Litigate Patents Covering Pharmaceutical Products
|
|
|
|
|
Post-election Employee Benefit Changes Expected from Washington
|
|
|
|
|
Executive Compensation Disclosure Update – 2009 Proxy Season, Part 1
|
|
|
|
|
Preparing for the fight of your life: Anatomy of a Health Care Fraud Prosecution
|
|
|
|
|
All Change – New Directions in Chinese Patent Law
|
|
|
|
|
CPSIA as of February 10 and Beyond: What the CPSC has Done So Far and What it Means to You
|
|
|
|
|
Health Care Fraud: Gearing up for Enforcement Directions for 2009
|
|
|
|
|
Section 409A(a) Proposed Income Inclusion Regulations: Revealing the Real Sting of 409A
|
|
|
|
|
Valuing Physician and Executive Compensation Arrangements: Fair Market Value & Commercial Reasonableness Thresholds
|
|
|
|
|
FAR Mandatory Disclosure Requirements – A Guide to Their Application and Consequences
|
|
|
|
|
Practical Tips on Protecting Attorney-Client Privilege and Work Product When Dealing With Auditors, Regulators, and Investigations
|
|
|
|
|
Electronic Health Care Records And The March Towards New Health Care Privacy Legislation
|
|
|
|
|
The Tangled Web of Financial Relationships between Industry and Institutions: Implications for Biomedical Research and Innovation
|
|
|
|
|
A Regulatory Enforcement Surge: RACs, MACs, QIOs, ZPICs and the OIG
|
|
|
|
|
Concept Searches: Has the Day Arrived for Computers to Replace Lawyers?
|
|
|
|
|
Regulating the Provider--Supplier Interface: Massachusetts and the Pharmaceutical and Medical Device Legislation
|
|
|
|
|
Coping With the Impending Wave of Commercial Real Estate Refinancings
|
|
|
|
|
A Comprehensive Overview of International ADR
|
|
|
|
|
Top 10 SEC Enforcement Developments of 2007 and What to Expect This Year
|
|
|
|
|
Auditing and Monitoring Physician Arrangements
|
|
|
|
|
Plan Administration After MetLife v. Glenn
|
|
|
|
|
Serious Preventable Medical Events - How Far Will This Go?
|
|
|
|
|
Securities Litigation 2008 -- Mid-Year Review
|
|
|
|
|
ADR for High Tech: What IP Litigators Should Know
|
|
|
|
|
Best Practices for IP: New Directions From Courts and Regulators Require Seismic Shifts
|
|
|
|
|
David v. Goliath and Issues that Occur in E-Discovery When the Two Sides are of Different Sizes
|
|
|
|
|
Steps to Quickly Resurrect an Ineffective Compliance Program
|
|
|
|
|
Downgrading Data to Inaccessible Format: Risky Business?
|
|
|
|
|
The New World of Compensation Committees: Five Best Practices Compensation Committees Need to Know to Answer Stakeholders
|
|
|
|
|
Discovery in Parallel Civil and Criminal Proceedings
|
|
|
|
|
Unclaimed Property - Why your company can’t afford NOT to be in Compliance (Part 2)
|
|
|
|
|
Unclaimed Property - Why your company can’t afford NOT to be in Compliance (Part 1)
|
|
|
|
|
Understanding the Impact of New Genomic Technologies in Toxic Tort and Workers Compensation Litigation
|
|
|
|
|
Discovery on E-Discovery: Fishing Expedition or Smoking Gun?
|
|
|
|
|
Pharmaceutical Payments and Generic Competition: Recent FTC Litigation and What Can be Done to Avoid Liability
|
|
|
|
|
Privacy and Security Obligations in an Insurance Firm's extended enterprise
|
|
|
|
|
Practical Advice on Clinical Trial Billing Under the (Mostly) Unchanged CMS Policy
|
|
|
|
